RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Perspective: Don’t Worry… after All, What Can FDA Do To Us?

Perspective: Don’t Worry… after All, What Can FDA Do To Us?

Posted 01 July 2011 | By Jeff Boatman, CQA

Quite a lot, actually!

Something that I often hear as I travel around the country preaching quality systems, agency guidance and best practices is some variety of, "I read the regulations and it does not say we have to do that, so we will not." Often, the person making that pronouncement is a lawyer or an MBA with little experience in the real world of regulated industry and who has no personal knowledge of the range of tools the US Food and Drug Administration (FDA)-or any regulatory body-has at its disposal to make life difficult for recalcitrant firms.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.